MME and intrahepatic cholangiocarcinoma: Wen et al. evaluated CD10 expression in 136 hepatic tumors (105 HCCs, 12 focal nodular hyperplasia [FNH], and 19 ICCs) and found CD10 expression in 61% of HCCs, 100% of FNH, and 31.6% of ICC tumors [28].